HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU alternative testing

This article was originally published in The Rose Sheet

Executive Summary

Conference on Alternative Methods to Animal Tests scheduled for Nov. 7 in Brussels will address policy issues such as "progress made in the area of alternative methods to animal tests at EU and international levels and...further possibilities to improve development, validation and legal acceptance of alternative methods," according to preliminary agenda. Program comprises presentations on animal welfare and societal aspects, risk assessment and alternative methods and future actions. Speakers include European Commission DG Research Director General Achilleas Mitsos and European Centre for the Validation of Alternative Methods Head of Unit Thomas Hartung. Sales of cosmetics tested on animals are prohibited in the EU beginning in 2009 under the Seventh Amendment to the Cosmetics Directive...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013286

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel